Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine for Postdural Puncture Headache
NCT05969119Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Jul 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pyridostigmine in post-dural puncture headache (PDPH), sponsored by Ain Shams University. Started Jul 2023; status: completed.
02
Drugs
pyridostigmine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT05969119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05969119.